Tagged with Acuitas

Beyond the Breakthrough: Scaling Cell & Gene Therapy in the USA
Curative, Approved & Out of Reach: Cell & Gene Therapy’s Access Reckoning
Thomas Madden – CEO, Acuitas Therapeutics
The bright future of mRNA technology – InConversation Podcast #Episode1:  w/Thomas D. Madden, Founder,  Acuitas Therapeutics
Vaccines: An Expanded R&D Playbook
Thomas D. Madden – CEO, Acuitas Therapeutics
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here